David Phillips

Prior to joining The Fool, David worked at YCharts, focusing on the healthcare and energy sectors. His journalism has appeared in Bloomberg BusinessWeek, Forbes, International Herald Tribune, and Kiplinger's Personal Finance. From 2008 to 2011, David was a reporter for CBS News Interactive. David is a Phi Beta Kappa graduate from the University of Vermont, having completed degree programs in Economics and Political Science. He also holds an M.B.A. from Boston College, with a concentration in Financial Statement Analysis.

10qdetective’s Activity

Sun Mar 23



10qdetective published an article 8:13 PM

Can AbbVie's Legacy Products Deliver Further Growth?

AbbVie is spending more than 16% of annual sales to develop new drugs that will lesson the drug maker's dependence on the rheumatoid arthritis drug Humira. Fortunately, the Chicago-based drug manufacturer has a stable of off-patent, legacy drugs that [more]

Wed Mar 5



10qdetective published an article 4:00 PM

AbbVie's Humira Still a Growth Engine

A published survey of rheumatologists suggests that growth in key European markets for AbbVie’s (NYSE: ABBV) flagship drug Humira could stall as biosimilar options become more prevalent. Absent longer-term safety data on these follow-on drugs, Humira [more]

Fri Feb 28



10qdetective published an article 1:59 PM

Pfizer Stubs Toe Without Celebrex

Pfizer (NYSE: PFE) remains committed to maintaining a leadership position in global pain-treatment markets, despite the upcoming loss of market exclusivity for Celebrex. Foolish investors should remain wary of management promises.

Tue Feb 25



10qdetective published an article 11:13 AM

Zogenix Stockholders Facing World of Pain?

The share price of Zogenix has soared more than 260% during the past year, driven by investor optimism for new opioid painkiller Zyhydro ER. Will the drug be a commercial success?

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 74791 out of 74876
Score -7250.64
Score Change Today -144.77
Accuracy 18.06%
Active Picks 190
Total Picks 230
Best Pick ACIIQ (+328.85)
Worst Pick NSLPQ (-100.04)
Average Score per Pick -31.52
Charms Earned 8
Highest Rated Favorite No Favorites Selected
Go to 10qdetective’s CAPS page

Boards Stats & Trivia

Board Posts 3
Recs Received 2
People who have rec'd these posts 2
Recs to Posts Ratio (last 30 days) N/A
Threads Started 2
Threads Started Percentage 66.67 %
Most Frequent Board Electronic Arts Inc.
Very First Post Re: Cadmium/Tellurium Issues? (8/6/2008)
Percentage of Posts Rec'd 33.33 %
Show 10qdetective’s 10 Latest Posts